The document discusses lung cancer, which is the leading cause of cancer death worldwide. It estimates that there are 1 million new lung cancer cases each year. Smoking is the primary risk factor, causing 78-90% of lung cancer cases. The document provides statistics on lung cancer incidence and mortality rates around the world. It also discusses risk factors, types of lung cancer, symptoms, functions of the lungs, and paraneoplastic syndromes that can occur in lung cancer patients.
- A 60 year old smoker presented for a routine physical and was found to have an abnormality on chest x-ray
- The next appropriate test would be a CT scan of the chest with IV contrast to further characterize any lung lesions found on CXR
- A CT-guided biopsy would not be the next test, as further imaging is needed first to identify and stage any potential lung cancer before invasive testing
The best answer is A) CT chest with IV contrast to further evaluate and characterize any lung abnormalities found on CXR before considering an invasive biopsy.
This document discusses lung cancer, including its anatomy, staging, diagnostic imaging, and treatment options. It provides details on the lobes of the lungs, lymph node stations, and the importance of lymph node involvement in staging. Imaging techniques like CT, PET, and PET/CT are described. Treatment depends on cancer type and stage, and may involve surgery, chemotherapy, radiation therapy, or a combination. Side effects of radiation treatment are also outlined.
This document summarizes key information about the management of lung carcinoma:
1. Lung cancer is the leading cause of cancer death worldwide. Smoking is the primary risk factor. Other risk factors include asbestos, radon gas, and genetic mutations.
2. Lung cancers commonly spread to local lymph nodes and distant sites like the brain, bones, liver and adrenal glands. Squamous cell carcinoma and small cell lung cancer often present with central masses while adenocarcinoma presents more peripherally.
3. Staging workup includes chest X-ray, sputum cytology, bronchoscopic biopsy, CT scans, and PET scans to determine the extent of disease for treatment planning.
REVIEW OF METHODS FOR DIAGNOSIS OF LUNG CANCERswankyshahir
This document discusses the diagnosis of lung cancer. It covers risk factors for lung cancer like smoking and air pollution. Screening methods are discussed, including low-dose CT screening which has been shown to decrease lung cancer mortality by 20% compared to chest x-rays. Diagnostic tools covered include sputum cytology, chest x-rays, CT scans, PET scans, bronchoscopy, biopsy and gene mutations associated with lung cancer like EGFR and KRAS. Early detection through low-dose CT screening and use of various diagnostic imaging and biopsy methods is key to improving outcomes for lung cancer patients.
This document provides information on lung cancer including:
- Lung cancer is one of the most common cancers worldwide and the leading cause of cancer death.
- Tobacco smoking is the main risk factor, causing over 70% of lung cancer deaths.
- Lung cancers are classified as small cell lung carcinoma and non-small cell lung carcinoma (NSCLC), which includes adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.
- NSCLC is more common and is diagnosed based on histopathological examination and immunohistochemistry (IHC) staining. Targeted therapies exist for mutations in EGFR and ALK genes.
- Cancer treatment is multidisciplinary, involving oncology care, clinical trials, and diagnosis through tissue examination. Early stage cancers are more curable than late stages.
- Oncology aims to provide lifelong care while minimizing harm through careful consideration of treatment intent (curative vs palliative), dose optimization, and multimodal approaches including surgery, chemotherapy, and targeted therapies.
- Surgical management of cancer involves diagnosis, staging, removal of the primary tumor and metastases when possible with curative intent or palliation, considering individual patient factors. Reconstruction aims to improve function and quality of life post-treatment.
- Non-small cell lung cancer is the most common malignancy worldwide and a leading cause of cancer death. It accounts for the majority (70-80%) of lung cancers.
- Imaging techniques like CT scans are important for accurately assessing the primary tumor and detecting metastasis. Positron emission tomography (PET) CT is more sensitive than size-based criteria alone for detecting lymph node involvement.
- Staging involves classifying the size and extent of the primary tumor and determining if the cancer has spread to lymph nodes or distant organs. Higher stages indicate larger primary tumors or spread beyond the lungs.
This document discusses lung cancer, including its risk factors, presentation, diagnosis, staging, prognosis, and different types. It notes that cigarette smoking is the leading risk factor, accounting for 85% of lung cancers. Radon exposure and asbestos are also significant risk factors. The main types of lung cancer are small cell carcinoma and non-small cell carcinoma (which includes adenocarcinoma, squamous cell carcinoma, and large cell carcinoma). Diagnosis requires biopsy and imaging can reveal solitary pulmonary nodules. Prognosis is generally poor due to lack of effective screening.
- A 60 year old smoker presented for a routine physical and was found to have an abnormality on chest x-ray
- The next appropriate test would be a CT scan of the chest with IV contrast to further characterize any lung lesions found on CXR
- A CT-guided biopsy would not be the next test, as further imaging is needed first to identify and stage any potential lung cancer before invasive testing
The best answer is A) CT chest with IV contrast to further evaluate and characterize any lung abnormalities found on CXR before considering an invasive biopsy.
This document discusses lung cancer, including its anatomy, staging, diagnostic imaging, and treatment options. It provides details on the lobes of the lungs, lymph node stations, and the importance of lymph node involvement in staging. Imaging techniques like CT, PET, and PET/CT are described. Treatment depends on cancer type and stage, and may involve surgery, chemotherapy, radiation therapy, or a combination. Side effects of radiation treatment are also outlined.
This document summarizes key information about the management of lung carcinoma:
1. Lung cancer is the leading cause of cancer death worldwide. Smoking is the primary risk factor. Other risk factors include asbestos, radon gas, and genetic mutations.
2. Lung cancers commonly spread to local lymph nodes and distant sites like the brain, bones, liver and adrenal glands. Squamous cell carcinoma and small cell lung cancer often present with central masses while adenocarcinoma presents more peripherally.
3. Staging workup includes chest X-ray, sputum cytology, bronchoscopic biopsy, CT scans, and PET scans to determine the extent of disease for treatment planning.
REVIEW OF METHODS FOR DIAGNOSIS OF LUNG CANCERswankyshahir
This document discusses the diagnosis of lung cancer. It covers risk factors for lung cancer like smoking and air pollution. Screening methods are discussed, including low-dose CT screening which has been shown to decrease lung cancer mortality by 20% compared to chest x-rays. Diagnostic tools covered include sputum cytology, chest x-rays, CT scans, PET scans, bronchoscopy, biopsy and gene mutations associated with lung cancer like EGFR and KRAS. Early detection through low-dose CT screening and use of various diagnostic imaging and biopsy methods is key to improving outcomes for lung cancer patients.
This document provides information on lung cancer including:
- Lung cancer is one of the most common cancers worldwide and the leading cause of cancer death.
- Tobacco smoking is the main risk factor, causing over 70% of lung cancer deaths.
- Lung cancers are classified as small cell lung carcinoma and non-small cell lung carcinoma (NSCLC), which includes adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.
- NSCLC is more common and is diagnosed based on histopathological examination and immunohistochemistry (IHC) staining. Targeted therapies exist for mutations in EGFR and ALK genes.
- Cancer treatment is multidisciplinary, involving oncology care, clinical trials, and diagnosis through tissue examination. Early stage cancers are more curable than late stages.
- Oncology aims to provide lifelong care while minimizing harm through careful consideration of treatment intent (curative vs palliative), dose optimization, and multimodal approaches including surgery, chemotherapy, and targeted therapies.
- Surgical management of cancer involves diagnosis, staging, removal of the primary tumor and metastases when possible with curative intent or palliation, considering individual patient factors. Reconstruction aims to improve function and quality of life post-treatment.
- Non-small cell lung cancer is the most common malignancy worldwide and a leading cause of cancer death. It accounts for the majority (70-80%) of lung cancers.
- Imaging techniques like CT scans are important for accurately assessing the primary tumor and detecting metastasis. Positron emission tomography (PET) CT is more sensitive than size-based criteria alone for detecting lymph node involvement.
- Staging involves classifying the size and extent of the primary tumor and determining if the cancer has spread to lymph nodes or distant organs. Higher stages indicate larger primary tumors or spread beyond the lungs.
This document discusses lung cancer, including its risk factors, presentation, diagnosis, staging, prognosis, and different types. It notes that cigarette smoking is the leading risk factor, accounting for 85% of lung cancers. Radon exposure and asbestos are also significant risk factors. The main types of lung cancer are small cell carcinoma and non-small cell carcinoma (which includes adenocarcinoma, squamous cell carcinoma, and large cell carcinoma). Diagnosis requires biopsy and imaging can reveal solitary pulmonary nodules. Prognosis is generally poor due to lack of effective screening.
ANATOMY,PATHOLOGY, INVESTIGATIVE WORK –UP AND STAGING OF LUNG CANCERLAKSHMI DEEPTHI GEDELA
Lung cancer is a leading cause of cancer death. It accounts for more deaths than breast, prostate, and colon cancers combined. The majority of lung cancers are related to tobacco use. There are two main types of lung cancer - non-small cell lung cancer (NSCLC) and small cell lung cancer. NSCLC makes up about 85% of cases and includes adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Small cell lung cancer accounts for about 15% of lung cancers. The anatomy of the lungs and patterns of spread are described. Common symptoms include cough, weight loss, and dyspnea. Risk factors are largely tied to tobacco smoke exposure.
This document provides information about small cell lung cancer (SCLC). It discusses that tobacco consumption is the primary cause of SCLC and accounts for 80-90% of lung cancer cases. It also notes that SCLC accounts for 13% of lung cancer worldwide. The natural history of untreated SCLC is rapid progression with a median survival of 2-4 months if extensive stage disease is present at diagnosis in approximately two thirds of patients. Diagnostic workup involves imaging like CT scans and PET scans to stage the cancer as well as biopsies to confirm the diagnosis. Prognostic factors like limited versus extensive stage disease and performance status impact survival outcomes.
This document provides an overview of the management of non-small cell lung cancer (NSCLC). It discusses the anatomy of the lung and lymph node mapping. The clinical features, diagnostic workup including imaging and staging are covered. The various treatment approaches for early, locally advanced and metastatic NSCLC including surgery, radiation therapy, chemotherapy and targeted therapy are summarized. Techniques for radiation therapy planning and delivery such as 3D conformal radiation therapy, stereotactic body radiation therapy, proton beam therapy and brachytherapy are also outlined.
This document discusses recent updates in lung cancer. It begins by noting that lung cancer is the leading cause of cancer death in the US and is often diagnosed at an advanced stage. Screening with low-dose CT scans can detect lung cancer earlier and has been shown to decrease lung cancer mortality by 20% compared to chest x-rays. The National Lung Screening Trial established low-dose CT screening as an effective screening method for those at high risk. Biomarker testing is important to identify driver mutations and guide targeted therapy options, though barriers like tissue availability and turnaround time exist. Osimertinib has demonstrated superior progression-free survival compared to earlier EGFR TKIs for patients with EGFR-mut
Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in lung tissues. The most common types are non-small cell lung cancer (NSCLC) and small cell lung cancer. Smoking is the leading risk factor. Symptoms may include cough, sputum production, chest pain, and shortness of breath. Diagnosis involves imaging tests and biopsy. Treatment depends on cancer type and stage but may include surgery, chemotherapy, radiation therapy, targeted therapy, and palliative care. Nursing management focuses on symptom management, education, and supporting the patient.
1. Lung metastasis is the second most common site of metastasis after the liver for many cancers. Complete resection of pulmonary metastases can improve survival for certain primary cancers like sarcoma, colon cancer, and breast cancer when the metastases are limited in number and size.
2. Pulmonary metastases can present radiographically in different patterns including cannonball lesions, miliary nodules, cavitating lesions, and endobronchial lesions. Diagnosis is typically made through CT scan, and biopsy may be needed to differentiate from a primary lung cancer.
3. Surgical resection is recommended for isolated, resectable metastases to potentially improve survival, with criteria including controlled primary cancer, no other distant metastases, and ability
This document discusses lung cancer treatment and recent advances. It begins with an introduction on lung cancer being the most common malignancy worldwide and a leading cause of cancer death. It then covers topics like incidence and prevalence rates, classification and pathology of lung cancer types (non-small cell vs. small cell), staging systems, risk factors, investigations, imaging, surgery, chemotherapy regimens for different stages, and prognosis factors. Key points emphasized are the rising rates of adenocarcinoma, importance of imaging and staging for determining treatment options, and multimodality therapy for locally advanced stages.
The document discusses an x-ray and CT scan of a 62-year-old male chronic smoker presenting with symptoms of dysphagia, difficulty breathing, and engorged chest veins. The x-ray shows an opacity in the right upper lobe and signs of a possible mass lesion. The CT scan confirms a homogeneous dense opacity in the right upper lobe along with pleural effusion and rib erosion. Key x-ray manifestations of lung cancer discussed include hilar enlargement, airway obstruction, peripheral masses, and cavitation.
This document discusses treatment options for lung cancer, including surgery, radiation therapy, chemotherapy, targeted therapy, and palliative care. It describes the different types and stages of non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), and provides details on standard treatment approaches based on cancer stage, including combinations of surgery, chemotherapy, and radiation therapy. Targeted therapies discussed include angiogenesis inhibitors like bevacizumab, and EGFR inhibitors like erlotinib and afatinib that target specific genetic mutations in NSCLC cells.
This document discusses lung cancer. It notes that lung cancer is the leading cause of cancer death in the US, with only a 15% 5-year survival rate. Men have a higher rate of lung cancer, though rates in women are increasing due to more women smoking. Around 90% of lung cancers are attributed to smoking. Occupational exposures like asbestos also increase lung cancer risk. Treatment depends on the cancer type and stage, and may include surgery, chemotherapy, radiation therapy, targeted drugs, or a combination.
Surgical Management for Non Small Cell Lung CancerAan Ardiansyah
1. Lung cancer is the leading cause of cancer death worldwide, with non-small cell lung cancer (NSCLC) accounting for 80% of cases.
2. Surgical resection remains the main treatment for early-stage NSCLC when possible. The standard surgical procedures are lobectomy, sleeve lobectomy, bilobectomy, and rarely pneumonectomy.
3. Accurate staging is important for determining resectability and prognosis. Mediastinal staging using techniques like PET, CT, mediastinoscopy, EBUS, and EUS is crucial for optimal treatment planning.
This document discusses non-small cell lung cancer (NSCLC), including its diagnosis, staging, types, and risk factors. It begins by describing lung anatomy and function. It then covers how NSCLC starts and spreads, the TNM staging system, the three main types of NSCLC (squamous cell carcinoma, adenocarcinoma, large cell carcinoma), and risk factors such as smoking, radon, asbestos, genetics, and other workplace exposures.
This document discusses mediastinal tumors, including their anatomy, types, clinical presentation, diagnosis, and treatment. The mediastinum contains vital structures like the heart, lungs and blood vessels. Tumors can arise primarily in the mediastinum or spread there from other areas. Common primary tumors include thymomas, lymphomas, and neurogenic tumors. Thymomas are often associated with myasthenia gravis and can be staged using the Masaoka system. Diagnosis involves imaging tests and biopsy. Treatment depends on the tumor type but may include surgery, radiation, chemotherapy or targeted therapy. Care before and after surgery aims to optimize the patient's condition and recovery.
This document discusses several clinical trials comparing different treatment approaches for esophageal cancer, including:
- Preoperative chemotherapy improved survival compared to surgery alone in some trials but not in others. High toxicity reduced benefits in some studies.
- Perioperative chemotherapy with fluorouracil and cisplatin significantly improved resection rates, survival, and disease-free survival compared to surgery alone.
- Chemoradiotherapy resulted in improved survival over radiotherapy alone or surgery alone in some trials for resectable esophageal cancer.
- Existing evidence did not clearly show preoperative radiotherapy alone improved survival over surgery alone for resectable esophageal cancer. Larger trials were needed.
Rectal cancer By Dr Efrem Ayalew WossenEfremAyalew
Rectal cancer develops in the tissues of the rectum. It is usually diagnosed through symptoms like bleeding, changes in bowel habits, and abdominal pain. Investigation may involve biopsy, imaging, and blood tests. Cancer in the rectum is staged according to how far it has spread locally and whether it has reached lymph nodes or distant sites. Treatment is usually surgery but may also involve chemotherapy and radiation. The type of surgery depends on how far the cancer has spread and includes local excision or removal of part of the rectum. Outcomes are best when cancer is treated with a multidisciplinary approach.
This document discusses the management of non-small cell lung cancer. It outlines the various treatment options depending on the stage of cancer, including surgery for early stages, radiation therapy, chemotherapy, and stereotactic body radiotherapy. It provides details on surgical procedures, radiation techniques, outcomes of stereotactic body radiotherapy, and the use of concurrent chemotherapy and radiation for locally advanced stages.
This document provides information about cancer of the larynx and lungs. It begins with an introduction to head and neck cancers, including laryngeal cancer, which accounts for about a quarter of head and neck cancers. It also notes that lung cancer is one of the most common cancers and is strongly linked to smoking. The document then describes the anatomy and functions of the respiratory system and larynx. It provides details on the definition, incidence, risk factors, staging, and research findings related to laryngeal cancer.
This document discusses lung cancer epidemiology, risk factors, pathology, and smoking cessation. It notes that lung cancer is largely caused by tobacco consumption and was rare before the 20th century. While smoking is the primary risk factor, some people who develop lung cancer have never smoked. The four main histological types are small cell lung cancer, adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Stopping smoking can avoid over 90% of lung cancer risk from tobacco. Occupational exposures like asbestos and radiation also increase lung cancer risk.
ANATOMY,PATHOLOGY, INVESTIGATIVE WORK –UP AND STAGING OF LUNG CANCERLAKSHMI DEEPTHI GEDELA
Lung cancer is a leading cause of cancer death. It accounts for more deaths than breast, prostate, and colon cancers combined. The majority of lung cancers are related to tobacco use. There are two main types of lung cancer - non-small cell lung cancer (NSCLC) and small cell lung cancer. NSCLC makes up about 85% of cases and includes adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Small cell lung cancer accounts for about 15% of lung cancers. The anatomy of the lungs and patterns of spread are described. Common symptoms include cough, weight loss, and dyspnea. Risk factors are largely tied to tobacco smoke exposure.
This document provides information about small cell lung cancer (SCLC). It discusses that tobacco consumption is the primary cause of SCLC and accounts for 80-90% of lung cancer cases. It also notes that SCLC accounts for 13% of lung cancer worldwide. The natural history of untreated SCLC is rapid progression with a median survival of 2-4 months if extensive stage disease is present at diagnosis in approximately two thirds of patients. Diagnostic workup involves imaging like CT scans and PET scans to stage the cancer as well as biopsies to confirm the diagnosis. Prognostic factors like limited versus extensive stage disease and performance status impact survival outcomes.
This document provides an overview of the management of non-small cell lung cancer (NSCLC). It discusses the anatomy of the lung and lymph node mapping. The clinical features, diagnostic workup including imaging and staging are covered. The various treatment approaches for early, locally advanced and metastatic NSCLC including surgery, radiation therapy, chemotherapy and targeted therapy are summarized. Techniques for radiation therapy planning and delivery such as 3D conformal radiation therapy, stereotactic body radiation therapy, proton beam therapy and brachytherapy are also outlined.
This document discusses recent updates in lung cancer. It begins by noting that lung cancer is the leading cause of cancer death in the US and is often diagnosed at an advanced stage. Screening with low-dose CT scans can detect lung cancer earlier and has been shown to decrease lung cancer mortality by 20% compared to chest x-rays. The National Lung Screening Trial established low-dose CT screening as an effective screening method for those at high risk. Biomarker testing is important to identify driver mutations and guide targeted therapy options, though barriers like tissue availability and turnaround time exist. Osimertinib has demonstrated superior progression-free survival compared to earlier EGFR TKIs for patients with EGFR-mut
Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in lung tissues. The most common types are non-small cell lung cancer (NSCLC) and small cell lung cancer. Smoking is the leading risk factor. Symptoms may include cough, sputum production, chest pain, and shortness of breath. Diagnosis involves imaging tests and biopsy. Treatment depends on cancer type and stage but may include surgery, chemotherapy, radiation therapy, targeted therapy, and palliative care. Nursing management focuses on symptom management, education, and supporting the patient.
1. Lung metastasis is the second most common site of metastasis after the liver for many cancers. Complete resection of pulmonary metastases can improve survival for certain primary cancers like sarcoma, colon cancer, and breast cancer when the metastases are limited in number and size.
2. Pulmonary metastases can present radiographically in different patterns including cannonball lesions, miliary nodules, cavitating lesions, and endobronchial lesions. Diagnosis is typically made through CT scan, and biopsy may be needed to differentiate from a primary lung cancer.
3. Surgical resection is recommended for isolated, resectable metastases to potentially improve survival, with criteria including controlled primary cancer, no other distant metastases, and ability
This document discusses lung cancer treatment and recent advances. It begins with an introduction on lung cancer being the most common malignancy worldwide and a leading cause of cancer death. It then covers topics like incidence and prevalence rates, classification and pathology of lung cancer types (non-small cell vs. small cell), staging systems, risk factors, investigations, imaging, surgery, chemotherapy regimens for different stages, and prognosis factors. Key points emphasized are the rising rates of adenocarcinoma, importance of imaging and staging for determining treatment options, and multimodality therapy for locally advanced stages.
The document discusses an x-ray and CT scan of a 62-year-old male chronic smoker presenting with symptoms of dysphagia, difficulty breathing, and engorged chest veins. The x-ray shows an opacity in the right upper lobe and signs of a possible mass lesion. The CT scan confirms a homogeneous dense opacity in the right upper lobe along with pleural effusion and rib erosion. Key x-ray manifestations of lung cancer discussed include hilar enlargement, airway obstruction, peripheral masses, and cavitation.
This document discusses treatment options for lung cancer, including surgery, radiation therapy, chemotherapy, targeted therapy, and palliative care. It describes the different types and stages of non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), and provides details on standard treatment approaches based on cancer stage, including combinations of surgery, chemotherapy, and radiation therapy. Targeted therapies discussed include angiogenesis inhibitors like bevacizumab, and EGFR inhibitors like erlotinib and afatinib that target specific genetic mutations in NSCLC cells.
This document discusses lung cancer. It notes that lung cancer is the leading cause of cancer death in the US, with only a 15% 5-year survival rate. Men have a higher rate of lung cancer, though rates in women are increasing due to more women smoking. Around 90% of lung cancers are attributed to smoking. Occupational exposures like asbestos also increase lung cancer risk. Treatment depends on the cancer type and stage, and may include surgery, chemotherapy, radiation therapy, targeted drugs, or a combination.
Surgical Management for Non Small Cell Lung CancerAan Ardiansyah
1. Lung cancer is the leading cause of cancer death worldwide, with non-small cell lung cancer (NSCLC) accounting for 80% of cases.
2. Surgical resection remains the main treatment for early-stage NSCLC when possible. The standard surgical procedures are lobectomy, sleeve lobectomy, bilobectomy, and rarely pneumonectomy.
3. Accurate staging is important for determining resectability and prognosis. Mediastinal staging using techniques like PET, CT, mediastinoscopy, EBUS, and EUS is crucial for optimal treatment planning.
This document discusses non-small cell lung cancer (NSCLC), including its diagnosis, staging, types, and risk factors. It begins by describing lung anatomy and function. It then covers how NSCLC starts and spreads, the TNM staging system, the three main types of NSCLC (squamous cell carcinoma, adenocarcinoma, large cell carcinoma), and risk factors such as smoking, radon, asbestos, genetics, and other workplace exposures.
This document discusses mediastinal tumors, including their anatomy, types, clinical presentation, diagnosis, and treatment. The mediastinum contains vital structures like the heart, lungs and blood vessels. Tumors can arise primarily in the mediastinum or spread there from other areas. Common primary tumors include thymomas, lymphomas, and neurogenic tumors. Thymomas are often associated with myasthenia gravis and can be staged using the Masaoka system. Diagnosis involves imaging tests and biopsy. Treatment depends on the tumor type but may include surgery, radiation, chemotherapy or targeted therapy. Care before and after surgery aims to optimize the patient's condition and recovery.
This document discusses several clinical trials comparing different treatment approaches for esophageal cancer, including:
- Preoperative chemotherapy improved survival compared to surgery alone in some trials but not in others. High toxicity reduced benefits in some studies.
- Perioperative chemotherapy with fluorouracil and cisplatin significantly improved resection rates, survival, and disease-free survival compared to surgery alone.
- Chemoradiotherapy resulted in improved survival over radiotherapy alone or surgery alone in some trials for resectable esophageal cancer.
- Existing evidence did not clearly show preoperative radiotherapy alone improved survival over surgery alone for resectable esophageal cancer. Larger trials were needed.
Rectal cancer By Dr Efrem Ayalew WossenEfremAyalew
Rectal cancer develops in the tissues of the rectum. It is usually diagnosed through symptoms like bleeding, changes in bowel habits, and abdominal pain. Investigation may involve biopsy, imaging, and blood tests. Cancer in the rectum is staged according to how far it has spread locally and whether it has reached lymph nodes or distant sites. Treatment is usually surgery but may also involve chemotherapy and radiation. The type of surgery depends on how far the cancer has spread and includes local excision or removal of part of the rectum. Outcomes are best when cancer is treated with a multidisciplinary approach.
This document discusses the management of non-small cell lung cancer. It outlines the various treatment options depending on the stage of cancer, including surgery for early stages, radiation therapy, chemotherapy, and stereotactic body radiotherapy. It provides details on surgical procedures, radiation techniques, outcomes of stereotactic body radiotherapy, and the use of concurrent chemotherapy and radiation for locally advanced stages.
This document provides information about cancer of the larynx and lungs. It begins with an introduction to head and neck cancers, including laryngeal cancer, which accounts for about a quarter of head and neck cancers. It also notes that lung cancer is one of the most common cancers and is strongly linked to smoking. The document then describes the anatomy and functions of the respiratory system and larynx. It provides details on the definition, incidence, risk factors, staging, and research findings related to laryngeal cancer.
This document discusses lung cancer epidemiology, risk factors, pathology, and smoking cessation. It notes that lung cancer is largely caused by tobacco consumption and was rare before the 20th century. While smoking is the primary risk factor, some people who develop lung cancer have never smoked. The four main histological types are small cell lung cancer, adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Stopping smoking can avoid over 90% of lung cancer risk from tobacco. Occupational exposures like asbestos and radiation also increase lung cancer risk.
Lung cancer; epidemiology,etiology and classificationdocpiash
Lung cancer is the leading cause of cancer death worldwide. Smoking is the primary risk factor, responsible for about 80% of lung cancer cases. Other risk factors include exposure to radon, asbestos, and other environmental carcinogens. Genetic factors also influence lung cancer risk. Lung cancer incidence varies globally and is highest in North America, Europe, and East Asia. In Bangladesh, lung cancer is the most common cancer in men and the 4th most common in women. Histologically, lung cancers are classified as small cell carcinomas, non-small cell carcinomas such as adenocarcinomas and squamous cell carcinomas, and other less common subtypes. Molecular analysis has revealed frequent mutations in genes
Lung cancer is a type of cancer that begins in the lungs. Your lungs are two spongy organs in your chest that take in oxygen when you inhale and release carbon dioxide when you exhale. Lung cancer is the leading cause of cancer deaths worldwide.
Lung Cancer Awareness By Epillo Health Systems EpilloHealth
November is officially lung cancer awareness month. The event started back in 1995 as lung cancer awareness day. As the lung cancer community and the lung cancer movement grew, the awareness activities increased and the day matured into Lung Cancer awareness month. This is a brief presentation for the awareness on Lung Cancer Awareness by the team Epillo.
This document provides information on tumors of the bronchus and lung, including bronchogenic carcinoma. It discusses:
- The majority (99%) of lung tumors are malignant, while less than 1% are benign. Non-small cell carcinoma accounts for 80% of lung cancers, while small cell carcinoma makes up 20-25%.
- Risk factors for bronchogenic carcinoma include tobacco smoking, industrial hazards, air pollution, and scarring from old infections. Symptoms depend on the location and size of the tumor. Diagnostic tests include chest imaging, biopsy, and PET scans.
- Treatment options are based on cancer type and stage. They include surgery, radiation, chemotherapy, targeted therapy, or a combination. Out
Lung cancer is a leading cause of cancer death worldwide. Smoking is the primary risk factor, causing 80-90% of cases. There are two main types: non-small cell lung cancer (NSCLC), which accounts for 80-85% of cases, and small cell lung cancer (SCLC), which accounts for 15-20% of cases and has a poorer prognosis. Symptoms are often nonspecific but may include cough, weight loss, and features of metastasis. Diagnosis involves imaging such as CT scanning and biopsy to determine cell type, stage, and guide treatment, which is usually surgical resection for early-stage disease or chemotherapy and radiation for later stages.
Define Structure of Cell
Define cancer
Explain Lung Cancer
Explain Epidemiology or statistics of Lung Cancer
Signs and Symptoms of Lung Cancer
risk factors of Lung cancer
methods used to diagnose lung cancer
treatment given to lung cancer
preventive measures of Lung Cancer
This document summarizes squamous malignant tumours and non-squamous malignant tumours of the head and neck region. It discusses cancers of the oral cavity, larynx, hypopharynx, nasopharynx, nose and paranasal sinuses. It also covers non-squamous cancers like thyroid cancer and salivary gland carcinoma. The major risk factors discussed are tobacco, alcohol, infection with HPV or EBV, certain genetic conditions and occupational exposures. Prevention strategies mentioned include screening and reducing risk factors like smoking.
This document discusses squamous and non-squamous malignant tumours of the head and neck region. It covers cancers of the oral cavity, larynx, nasopharynx, nose/paranasal sinuses and thyroid. It details the incidence, risk factors and aetiology of these cancers. Tobacco use and alcohol consumption are major risk factors. Infection with Epstein-Barr virus increases risk of nasopharyngeal cancer. Diet low in iodine and radiation exposure can increase thyroid cancer risk. Prognosis depends on cancer type and stage at diagnosis.
This document discusses squamous and non-squamous malignant tumours of the head and neck region. It covers cancers of the oral cavity, larynx, nasopharynx, nose/paranasal sinuses and salivary glands. Key information includes the most common types, risk factors like tobacco and alcohol use, incidence rates varying by location and gender, and survival rates. Genetic and environmental causes are described for several of the cancers.
This document summarizes statistics and information about lung cancer incidence and prevalence in the UK and worldwide. It finds that lung cancer is the 2nd most common cancer in men and 3rd in women in the UK. Smoking is the leading cause of lung cancer, responsible for over 80% of cases. Lung cancer rates are higher in more deprived areas and in northern regions of the UK. Survival rates have remained low, at around 7% after 5 years.
This document provides information about laryngeal cancer including its definition, risk factors, clinical presentation, diagnosis, staging, and treatment. It defines laryngeal cancer as a malignant tumor that forms in the larynx (voice box) and discusses the anatomy and functions of the larynx. Risk factors include age, gender, tobacco use, alcohol use and HPV infection. Signs may include hoarseness, sore throat, cough and difficulty swallowing. Staging involves endoscopy, imaging and biopsy. Treatment options covered are radiation therapy, surgery such as laryngectomy, and chemotherapy. Nursing care focuses on education, managing anxiety, and preparing the patient for post-operative communication changes.
This document summarizes information about several types of solid tumors. It provides details about a 56 year old male patient presenting with hemoptysis and a lung mass. It discusses risk factors, symptoms, diagnostic tests and staging for lung cancer. It also summarizes information about other cancers such as head and neck, esophageal, gastric, colorectal, pancreatic and anal cancers.
This document summarizes lung cancer, discussing its epidemiology, etiology, pathogenesis, histology, molecular genetics, clinical presentation, and more. It notes that lung cancer is the most common cancer worldwide, with the majority (90-95%) being carcinomas. Cigarette smoking is the main environmental risk factor, though genetic factors also contribute to risk. The document describes the different histological subtypes and their characteristic molecular mutations. Clinical symptoms vary depending on tumor location and spread. Prognosis remains poor with a 5-year survival rate of only 16%.
The document discusses lung cancer, including its causes, risk factors, symptoms, diagnosis, staging, and treatment options. Lung cancer is the leading cause of cancer death in men and women. Key risk factors include smoking and exposure to secondhand smoke, radon, asbestos, and other carcinogens. Common symptoms are cough, shortness of breath, wheezing, and chest pain. Diagnosis involves imaging tests and biopsies. Treatment may involve surgery, chemotherapy, radiation therapy, and other approaches depending on the cancer's stage and type.
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive functioning. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms.
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive function. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms for those who already suffer from conditions like anxiety and depression.
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive functioning. Exercise boosts blood flow, releases endorphins, and promotes changes in the brain which help enhance one's emotional well-being and mental clarity.
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive functioning. Exercise causes chemical changes in the brain that may help boost feelings of calmness, happiness and focus.
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive function. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms for those who already suffer from conditions like anxiety and depression.
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive function. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms for those who already suffer from conditions like anxiety and depression.
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive functioning. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms.
The document provides information about the Post Graduate Common Entrance Test to be held on July 1st, 2017 from 2:30 pm to 4:30 pm for various Masters programs. It lists instructions for candidates regarding filling the answer sheet correctly and details about the structure of the test, which will consist of 75 multiple choice questions worth 100 marks to be completed within 120 minutes. Candidates are advised to carefully read and follow the guidelines for appearing in the exam.
Civil Service 2019 Prelims Previous Question Paper - 2Eneutron
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive function. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms.
Civil Service 2019 Prelims Previous Question Paper - 1Eneutron
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive function. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms.
Civil Service 2018 Prelims Previous Question Paper - 2Eneutron
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive functioning. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms.
Civil Service 2018 Prelims Previous Question Paper - 1Eneutron
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive functioning. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms.
Civil Service 2017 Prelims Previous Question Paper - 2Eneutron
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive function. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms for those who already suffer from conditions like depression and anxiety.
Civil Service 2017 Prelims Previous Question Paper - 1Eneutron
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive function. Exercise stimulates the production of endorphins in the brain which elevate mood and reduce stress levels.
This document contains the question paper for SNAP 2013 along with the answers to the 150 multiple choice questions. It directs test takers to an online site to attempt previous SNAP papers and provides information about exam preparation resources available on the site such as daily practice questions, preparation strategies, coaching classes, and current affairs.
This document contains the question paper for SNAP 2014 along with the answers to the 150 multiple choice questions. It provides a link to attempt similar past year papers online and lists exam preparation resources for SNAP like daily practice questions, preparation strategies, coaching class recommendations, and current affairs.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Our backs are like superheroes, holding us up and helping us move around. But sometimes, even superheroes can get hurt. That’s where slip discs come in.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
2. Cancer morbidityCancer morbidity
(patients per year)(patients per year)
Lungs 1 350 000 (12,3%)Lungs 1 350 000 (12,3%)
Breast 1 050 000 (10,4%)Breast 1 050 000 (10,4%)
Colon and rectum 945 000 (9,4%)Colon and rectum 945 000 (9,4%)
Stomach 876 000 (8,7%)Stomach 876 000 (8,7%)
Hepar 564 000 (5,6%)Hepar 564 000 (5,6%)
Prostate 543 000 (5,4%)Prostate 543 000 (5,4%)
3. What is lung cancer?What is lung cancer?
• The leading cause of cancer death among men and
women
• Begins when cells in the lung grow out of control and
form a tumor
• There are two main types of lung cancer: non-small
cell and small cell
4. Famous people who died of lung cancerFamous people who died of lung cancer
Georg VIGeorg VI, (1895-1952)
King of Great Britain
Rudolf AbelRudolf Abel (Fisher), (1903-1971)
secret service agent
Sergej ParadjanovSergej Paradjanov, (1924- 1990)
film producer
Walter Elias "Walt" Disney"Walt" Disney, (1901–1966)
screenwriter
Dmitri ShostakovichDmitri Shostakovich, (1906-1975)
composer
6. Lung cancer in the world in recent yearsLung cancer in the world in recent years
the incidence for men increased by 44%, women - 75%the incidence for men increased by 44%, women - 75%
Маly 5,3 1,5
Brasil 67,5 14,4
USA, white
USA, afro-american
61,3
99,1
33,8
38,5
China
Japan
India
56,1
39,6
14,5
18,2
10,3
3,7
France
Germany
Italy
Ukraine
67,4
70,9
82,7
77,6
7,2
10,3
14,9
13,8
New Zeland,
Māori
46,5
99,7
18,2
72,9
manman womanwoman
7. The incidence of male populationThe incidence of male population
1
5
2 3
4
1
2
3
4
Lung
Colon & rectum
Prostate
Hepar
Stomach
8. The incidence of female populationThe incidence of female population
3
2
2
5
1
1
Lung
Uterus
Stomach
Colon & rectum
Breast
4
34
9.
10.
11. Lung cancerLung cancer
• Lung cancer is the #1 cancer killer worldwideLung cancer is the #1 cancer killer worldwide
• World Health Organization estimates 1 million newWorld Health Organization estimates 1 million new
cases each yearcases each year
• 200,000 cases annually in U.S.200,000 cases annually in U.S.
• More than breast, prostate and colon combinedMore than breast, prostate and colon combined
12. Risk factorsRisk factors
SmokingSmoking
• 78-90% of lung cancer is caused by tobacco smoking
• Smokers have a 13.3X risk of developing lung cancer than
nonsmokers
√ Amount (pack years = # packs/day x # yrs)
- 10X higher for 1 PPD or less
- 20X higher for greater than 1 PPD
√ Age of smoking onset
√ Product smoked (tar/nicotine content, filters)
√ Depth of inhalation
√ Gender
• Up to 15% of lung cancers in people who do not smoke are
believed to be caused by second hand smoke
13. Tobacco’s toll in U.S.Tobacco’s toll in U.S.
• Leading preventable cause of death, killingLeading preventable cause of death, killing
>400,000/yr>400,000/yr
• Tobacco kills more people than from AIDS,Tobacco kills more people than from AIDS,
alcohol, car accidents, murders, suicides, andalcohol, car accidents, murders, suicides, and firesfires
COMBINEDCOMBINED
• Up to 90% of lung cancer cases, 1/3 of total cancerUp to 90% of lung cancer cases, 1/3 of total cancer
deaths, and 1 in 5 deaths from heart disease aredeaths, and 1 in 5 deaths from heart disease are
tobacco relatedtobacco related
• Tobacco results in $89 billion in annual health careTobacco results in $89 billion in annual health care
costscosts
15. Smoking - the main cause of lung cancerSmoking - the main cause of lung cancer
smoker's lungsmoker's lung
5
years
10
years
15
years
20
years
16. Risk Factors
• AsbestosAsbestos
√ Associated with lung cancer, malignant mesothelioma,
and pulmonary fibrosis
√ Increases lung cancer risk by 5X
√ Synergistic with tobacco, 80-90X lung cancer risk!
• RadonRadon
√ Uranium miners, ? household exposure
√ Causes approximately 2-3% of lung cancers
• Possibly HIV infectionPossibly HIV infection
√ State of Texas Health Department suggested at 6.5X
increase of lung cancers
√ Increase not reported in other large series
18. The main periods of development ofThe main periods of development of
malignant lung tumorsmalignant lung tumors
• LatencyLatency of the tumor - the time from the beginning of theof the tumor - the time from the beginning of the
carcinogen to the appearance of tumor, diagnosed, lastscarcinogen to the appearance of tumor, diagnosed, lasts 10-1710-17
years, depending on the intensity of division ofyears, depending on the intensity of division of cancer cells,cancer cells,
which determine its malignancy. Thenwhich determine its malignancy. Then continuedcontinued
asymptomaticasymptomatic preclinical periodpreclinical period of tumor development,of tumor development,
and with the clinical symptoms appearand with the clinical symptoms appear clinical periodclinical period begins.begins.
• On average, for the development of tumor diameter of 1-2 mmOn average, for the development of tumor diameter of 1-2 mm
(1-2 million tumor cells) to about 20 doubling of tumor mass(1-2 million tumor cells) to about 20 doubling of tumor mass..
• In half of cases of lung cancer tumor grows to a diameter of 1 cmIn half of cases of lung cancer tumor grows to a diameter of 1 cm
(1 billion tumor cells) for 7 or more years.(1 billion tumor cells) for 7 or more years.
19. What is the function of the lungs?What is the function of the lungs?
• The lungs consist of five lobes,The lungs consist of five lobes,
three in the right lung and two inthree in the right lung and two in
the left lungthe left lung
• Most cells in the lung areMost cells in the lung are
epithelial cells, which line theepithelial cells, which line the
breathing passages and producebreathing passages and produce
mucus, which lubricates andmucus, which lubricates and
protects the lungsprotects the lungs
• The main function of the lungs isThe main function of the lungs is
to allow oxygen from the air toto allow oxygen from the air to
enter the bloodstream for deliveryenter the bloodstream for delivery
to the rest of the bodyto the rest of the body
21. Paraneoplastyc syndrome in lung cancerParaneoplastyc syndrome in lung cancer
nail deformity phalanxes as "drum sticks"nail deformity phalanxes as "drum sticks"
22. Paraneoplastyc syndrome in lung cancerParaneoplastyc syndrome in lung cancer
Cushing’s syndromeCushing’s syndrome
23. Paraneoplastyc syndrome in lung cancerParaneoplastyc syndrome in lung cancer
ossificated periostitisossificated periostitis
24. Paraneoplastyc syndrome in lung cancerParaneoplastyc syndrome in lung cancer
Bazeks syndromeBazeks syndrome::
erythema, hyperkeratosis, keratodermia on the skin of arm,erythema, hyperkeratosis, keratodermia on the skin of arm,
feet, face, nose, ears, knees, elbows, and torsofeet, face, nose, ears, knees, elbows, and torso
25. Paraneoplastyc syndrome in lung cancerParaneoplastyc syndrome in lung cancer
Bazeks syndromeBazeks syndrome::
erythema, hyperkeratosis, keratodermia on the skin oferythema, hyperkeratosis, keratodermia on the skin of
arm, feet, face, nose, ears, knees, elbows, and torsoarm, feet, face, nose, ears, knees, elbows, and torso
26. Paraneoplastyc syndrome in lung cancerParaneoplastyc syndrome in lung cancer
black acantosisblack acantosis
27. History and presentation of lung cancerHistory and presentation of lung cancer
Natural historyNatural history
· Multiple areas of carcinoma in situ have been found· Multiple areas of carcinoma in situ have been found
in the bronchi of cigarette smokersin the bronchi of cigarette smokers
· Lung carcinoma, especially small-cell, metastatizes· Lung carcinoma, especially small-cell, metastatizes
early and widely, most commonly to brain, bone,early and widely, most commonly to brain, bone,
lung, liver, adrenals, and skinlung, liver, adrenals, and skin
· Initial spread is usually first to the hilar nodes,· Initial spread is usually first to the hilar nodes,
secondly to the mediastinal nodes, and thirdly tosecondly to the mediastinal nodes, and thirdly to
the scalene nodesthe scalene nodes
28. Lung cancer and early detectionLung cancer and early detection
• No tests are recommended for screening the generalNo tests are recommended for screening the general
populationpopulation
• A low-dose helical computerized tomography (CT orA low-dose helical computerized tomography (CT or
CAT) scan is currently being studied for this purposeCAT) scan is currently being studied for this purpose
• Any person who is at increased risk due to smokingAny person who is at increased risk due to smoking
or asbestos exposure should discuss the benefits andor asbestos exposure should discuss the benefits and
limitations of a screening CT scan with his or herlimitations of a screening CT scan with his or her
doctordoctor
29. What are the symptoms of lung cancer?
• Fatigue (tiredness)Fatigue (tiredness)
• CoughCough
• Shortness of breathShortness of breath
• Chest painChest pain
• Loss of appetiteLoss of appetite
• Coughing up phlegmCoughing up phlegm
• Hemoptysis (coughing up blood)Hemoptysis (coughing up blood)
• If cancer has spread, symptoms include bone pain,If cancer has spread, symptoms include bone pain,
difficulty breathing, abdominal pain, headache,difficulty breathing, abdominal pain, headache,
weakness, and confusionweakness, and confusion
30. Clinical featuresClinical features
• Asymptomatic: any mass noted on CXR is cancerAsymptomatic: any mass noted on CXR is cancer
until proven otherwiseuntil proven otherwise
· Cough (most common - 75%)· Cough (most common - 75%)
· Anorexia and weight loss (70%)· Anorexia and weight loss (70%)
· Dyspnea (60%)· Dyspnea (60%)
· Chest pain (50%)· Chest pain (50%)
· Hemoptysis (33%)· Hemoptysis (33%)
· Other: wheezing, bone pain, pneumonia, pleural· Other: wheezing, bone pain, pneumonia, pleural
effusion, hoarseness, Cushing's syndrome,effusion, hoarseness, Cushing's syndrome,
inappropriate ADH secretion, eosinophilia (tumorinappropriate ADH secretion, eosinophilia (tumor
necrosis) and neuromyopathiesnecrosis) and neuromyopathies
31. How is lung cancer evaluated?How is lung cancer evaluated?
• Because almost all patients will have a tumor in the lung, aBecause almost all patients will have a tumor in the lung, a
chest x-ray or CT scan of the chest is performedchest x-ray or CT scan of the chest is performed
• The diagnosis must be confirmed with a biopsyThe diagnosis must be confirmed with a biopsy
• The location(s) of all sites of cancer is determined byThe location(s) of all sites of cancer is determined by
additional CT scans, PET (positron emission tomography)additional CT scans, PET (positron emission tomography)
scans, and MRI (magnetic resonance imaging)scans, and MRI (magnetic resonance imaging)
• It is important to find out if cancer started in the lung orIt is important to find out if cancer started in the lung or
somewhere else in the body. Cancer arising in other parts ofsomewhere else in the body. Cancer arising in other parts of
the body can spread to the lung as wellthe body can spread to the lung as well
32. Diagnosis and stagingDiagnosis and staging
• CXR with review of previous filmsCXR with review of previous films
· Chest CT· Chest CT
· Sputum cytology· Sputum cytology
· Bronchoscopy - washings, brushings, and· Bronchoscopy - washings, brushings, and
transbronchial biopsy: definitive diagnosis intransbronchial biopsy: definitive diagnosis in
about 85% of patientsabout 85% of patients
· CT-transthoracic needle aspiration: near-100%· CT-transthoracic needle aspiration: near-100%
specificity, false-negative rate 15%specificity, false-negative rate 15%
· Open lung biopsy (VATS or thoracotomy)· Open lung biopsy (VATS or thoracotomy)
33. TNM staging overviewTNM staging overview
Stage IStage I
All T1 tumors and T2 tumors without lymph nodeAll T1 tumors and T2 tumors without lymph node
metastasismetastasis
Stage IIStage II
T1 and T2 tumors with involvement of ipsilateralT1 and T2 tumors with involvement of ipsilateral
hilar nodeshilar nodes
Stage IIIaStage IIIa Ipsilateral mediastinal diseaseIpsilateral mediastinal disease
Stage IIIbStage IIIb More widespread diseaseMore widespread disease
Stage IVStage IV Unresectable diseaseUnresectable disease
34. TNM staging for lung carcinomaTNM staging for lung carcinoma
Primary Tumor (T)Primary Tumor (T)
TXTX:: Primary tumor cannot be assessed, or tumorPrimary tumor cannot be assessed, or tumor
proven by the presence of malignant cells in sputumproven by the presence of malignant cells in sputum
or bronchial washings but not visualized by imagingor bronchial washings but not visualized by imaging
or bronchoscopyor bronchoscopy
35. Т1
Т2
Т2
Т1
T0T0 No evidence of primary tumorNo evidence of primary tumor
TisTis : Carcinoma in situ: Carcinoma in situ
T1T1 : Tumor 3 cm or less in greatest dimension, surrounded by lung or: Tumor 3 cm or less in greatest dimension, surrounded by lung or
visceral pleura, without bronchoscopic evidence of invasion morevisceral pleura, without bronchoscopic evidence of invasion more
proximal than the lobar bronchusproximal than the lobar bronchus
T2T2 : Tumor with any of the: Tumor with any of the
following features of size orfollowing features of size or
extent:extent:
· More than 3 cm in greatest· More than 3 cm in greatest
dimensiondimension
· Involving main bronchus, 2· Involving main bronchus, 2
cm or more distal to the carinacm or more distal to the carina
· Invading the visceral pleura· Invading the visceral pleura
· Associated with atelectasis or· Associated with atelectasis or
obstructive pneumonitis thatobstructive pneumonitis that
extends to the hilar region butextends to the hilar region but
does not involve the entiredoes not involve the entire
lunglung
Primary tumor (T)Primary tumor (T)
36. Т3
Т3
Т3
Т3
T3T3 : Tumor of any size that:: Tumor of any size that:
· directly invades the chest wall (including superior sulcus· directly invades the chest wall (including superior sulcus
tumors), diaphragm, mediastinal pleura, or parietal pericardiumtumors), diaphragm, mediastinal pleura, or parietal pericardium
· is located in the main bronchus less than 2 cm distal to the· is located in the main bronchus less than 2 cm distal to the
carina but without involvement of the carinacarina but without involvement of the carina
· is associated with atelectasis or obstructive pneumonitis of the· is associated with atelectasis or obstructive pneumonitis of the
entire lungentire lung
Primary tumor (T)Primary tumor (T)
37. Т4
Т4
T4T4 : Tumor of any size that:: Tumor of any size that:
· invades the mediastinum, heart, great vessels, trachea, esophagus,· invades the mediastinum, heart, great vessels, trachea, esophagus,
vertebral body, or carinavertebral body, or carina
· is associated with a malignant pleural effusion· is associated with a malignant pleural effusion
Primary tumor (T)Primary tumor (T)
38. N1
Regional Lymph Nodes (N)Regional Lymph Nodes (N)
NXNX: Regional lymph nodes cannot be assessed: Regional lymph nodes cannot be assessed
N0N0: No regional lymph nodes metastasis: No regional lymph nodes metastasis
N1N1: Metastasis in ipsilateral peribronchial and/or ipsilateral: Metastasis in ipsilateral peribronchial and/or ipsilateral
hilar lymph nodes, including direct extensionhilar lymph nodes, including direct extension
TNM staging for lung carcinomaTNM staging for lung carcinoma
39. N2
N2
Regional Lymph Nodes (N)Regional Lymph Nodes (N)
N2N2:: metastasis in ipsilateral mediastinal, paratracheal,metastasis in ipsilateral mediastinal, paratracheal,
bifurcationalbifurcational and/or subcarinaland/or subcarinal lymph node(s)lymph node(s)
TNM staging for lung carcinomaTNM staging for lung carcinoma
40. N3
N3
N3
N3N3:: Metastasis in contralateral mediastinal, contralateralMetastasis in contralateral mediastinal, contralateral
hilar, ipsilateral or contralateral scalene or supraclavicularhilar, ipsilateral or contralateral scalene or supraclavicular
lymph node(s)lymph node(s)
Regional Lymph Nodes (N)Regional Lymph Nodes (N)TNM staging for lung carcinomaTNM staging for lung carcinoma
41. Distant Metastases (M)Distant Metastases (M)
• MXMX: Presence of distant metastasis cannot be assessed: Presence of distant metastasis cannot be assessed
• M0M0: No distant metastasis: No distant metastasis
• M1M1: Distant metastasis: Distant metastasis
TNM staging for lung carcinomaTNM staging for lung carcinoma
42.
43.
44.
45. Small-cell lung cancerSmall-cell lung cancer
metastatic lesion of skin and face soft tissuemetastatic lesion of skin and face soft tissue
46. Clinical forms of lung cancerClinical forms of lung cancer
The central lung cancer (40-60%) - a tumor that develops in the
mucosa of large (main, partial, segmental) bronchus and
accompanied by the development of bronchial obtstructive
syndrome: endobronchial cancer; peribronchial nodular cancer;
ramified cancer.
Peripheral lung cancer (40-50%) - a tumor growing in the mucosa
of small and smaller bronchus and grows as a unit, located in
peripheral lung divisions: nodular cancer; pneumonia-look
cancer, apical lung cancer (Pancoast).
Atypical forms of lung cancer (5-10%): mediastinal form -
germination into mediastinum and lesions ofmediastinal lymph
nodes, bone form - extensive metastatic bone lesions, brain
form - metastatic brain with the development of neurologic
symptoms.
47. Clinical forms of lung cancerClinical forms of lung cancer
atypical “brain” formatypical “brain” form
48. Clinical forms of lung cancerClinical forms of lung cancer
“vein cava superior compression syndrome”“vein cava superior compression syndrome”
in the mediastinal form of lung cancerin the mediastinal form of lung cancer
49. Clinical forms of lung cancerClinical forms of lung cancer
atypical mediastinal form withatypical mediastinal form with
“vein cava superior compression syndrome”“vein cava superior compression syndrome”
50. Clinical forms of lung cancerClinical forms of lung cancer
apical cancer (Pancoast H., 1924)apical cancer (Pancoast H., 1924)
Horner's syndrome - ptosis, miosis, enoftalm on the rightHorner's syndrome - ptosis, miosis, enoftalm on the right
51. Metastasis of lung cancerMetastasis of lung cancer
• metastasesmetastases in the liverin the liver - 40% of patients- 40% of patients
• metastasesmetastases in the brainin the brain - in the 25-40%- in the 25-40%
• metastasesmetastases in the bonein the bone - in the 15-20%- in the 15-20%
• metastasesmetastases in the adrenal glandsin the adrenal glands - in the 25-30%- in the 25-30%
• metastasesmetastases in the kidneysin the kidneys - in 15-20%- in 15-20%
52. Metastasis of lung cancerMetastasis of lung cancer
in the adrenal glandsin the adrenal glands
53. Metastasis of lung cancerMetastasis of lung cancer
in the brainin the brain
54. Metastasis of lung cancerMetastasis of lung cancer
in the spinein the spine
55. Forms of growth of the central lung cancerForms of growth of the central lung cancer
1 – endobronchial1 – endobronchial
2 – endoperibronchial2 – endoperibronchial
3 – peribronchial3 – peribronchial
1
23
57. Central lung cancerCentral lung cancer
Central cancer comes from theCentral cancer comes from the
large bronchus: the main, lobal, orlarge bronchus: the main, lobal, or
segmental.segmental.
Type of growth: endobronchial,Type of growth: endobronchial,
peribronchial, and mixed.peribronchial, and mixed.
Central cancer gradually leads toCentral cancer gradually leads to
the bronchus and the developmentthe bronchus and the development
of obturation atelectasis.of obturation atelectasis.
In the early stages revealed cough,In the early stages revealed cough,
hemoptysis, subfebrility.hemoptysis, subfebrility.
Tumor is not visible on the X-ray,Tumor is not visible on the X-ray,
it can be detected only atit can be detected only at
bronchoscopy.bronchoscopy.
58. Peripheral lung cancerPeripheral lung cancer
1
3
5
2
4
Peripheral cancer goesPeripheral cancer goes
of small bronchi and grows as aof small bronchi and grows as a
unit in a peripheral pulmonaryunit in a peripheral pulmonary
areas (1)areas (1)
In early stages - asymptomatic,In early stages - asymptomatic,
symptoms (pain, cough,symptoms (pain, cough,
hemoptysis) appear duringhemoptysis) appear during
germination chest wall, largegermination chest wall, large
bronchi and vessels (2, 3)bronchi and vessels (2, 3)
Peripheral tumor detected on filmPeripheral tumor detected on film
in 2 projections but can "hide" forin 2 projections but can "hide" for
shadow of diaphragm, heart, andshadow of diaphragm, heart, and
mediastinum (4, 5)mediastinum (4, 5)
61. Radiography and CTRadiography and CT
atelectasis of the lower lobe of the right lungatelectasis of the lower lobe of the right lung
injuried lung volume reduction,
mediastinum shadow dislocates in the injuried side
high standing diaphragm domes
62. Radiogram and endoscopyRadiogram and endoscopy
atelectasis of the right lung middle lobeatelectasis of the right lung middle lobe
63. RadiographyRadiography
cancer of the left lung lower lobecancer of the left lung lower lobe
?
Tumor does not seen at the direct X-ray,Tumor does not seen at the direct X-ray,
but clearly visible on the lateral imagebut clearly visible on the lateral image
and CTand CT
66. Computed tomography in the diagnosis of lung cancerComputed tomography in the diagnosis of lung cancer
probability of lymph node metastases lesions depending on their size:probability of lymph node metastases lesions depending on their size:
less than 10 mm - 11%, 10 - 19 mm - 32% more than 20mm - 51%less than 10 mm - 11%, 10 - 19 mm - 32% more than 20mm - 51%
72. Bronchoscopy in the diagnosis of lung cancerBronchoscopy in the diagnosis of lung cancer
73. Bronchoscopy in the diagnosis of lung cancerin the diagnosis of lung cancer
Transbronchial bifurcation lymph node biopsyTransbronchial bifurcation lymph node biopsy
74. Bronchoscopy in the diagnosis of lung cancerin the diagnosis of lung cancer
Endoscopic removal of tracheal fibromaEndoscopic removal of tracheal fibroma
82. Most informative diagnostic methods of lung cancerMost informative diagnostic methods of lung cancer
computed tomography, PET scanning, and their combinationcomputed tomography, PET scanning, and their combination
83. How is lung cancer treated?How is lung cancer treated?
• Treatment depends on the stage and type of lung cancerTreatment depends on the stage and type of lung cancer
• SurgerySurgery
• Radiation therapyRadiation therapy
• Chemotherapy (options include a combination of drugs)Chemotherapy (options include a combination of drugs)
• Targeted therapyTargeted therapy
• Lung cancer is usually treated with a combination of therapiesLung cancer is usually treated with a combination of therapies
84. Treatment OptionsTreatment Options
Surgery to remove tumors, chemotherapy, and radiation - inSurgery to remove tumors, chemotherapy, and radiation - in
combination or alone - are common treatments for lung cancer.combination or alone - are common treatments for lung cancer.
SurgerySurgery –an operation to remove cancer cells.–an operation to remove cancer cells.
Radiation therapyRadiation therapy – uses high-energy rays to shrink or kill– uses high-energy rays to shrink or kill
cancer cells.cancer cells.
ChemotherapyChemotherapy – uses anticancer drugs that attack cancer cells– uses anticancer drugs that attack cancer cells
and normal cells. These drugs are usually givenand normal cells. These drugs are usually given
by injection or by mouth.by injection or by mouth.
Treatment options depend on cancer type and stage of cancer.Treatment options depend on cancer type and stage of cancer.
85.
86.
87. Cancer treatment: surgeryCancer treatment: surgery
• The tumor and the nearby lymph nodes in the chestThe tumor and the nearby lymph nodes in the chest
are typically removed to offer the best chance for cureare typically removed to offer the best chance for cure
• For non-small cell lung cancer, a lobectomy (removalFor non-small cell lung cancer, a lobectomy (removal
of the entire lobe where the tumor is located), hasof the entire lobe where the tumor is located), has
shown to be most effectiveshown to be most effective
• Surgery may not be possible in some patientsSurgery may not be possible in some patients
88. Cancer treatment: chemotherapyCancer treatment: chemotherapy
• Drugs used to kill cancer cellsDrugs used to kill cancer cells
• A combination of medications is often usedA combination of medications is often used
• May be prescribed before or after surgery, or before,May be prescribed before or after surgery, or before,
during, or after radiation therapyduring, or after radiation therapy
• Can improve survival and lessen lung cancerCan improve survival and lessen lung cancer
symptoms in all patients, even those with widespreadsymptoms in all patients, even those with widespread
lung cancerlung cancer
89. Cancer treatment: radiation therapyCancer treatment: radiation therapy
• The use of high-energy x-rays or other particles toThe use of high-energy x-rays or other particles to
destroy cancer cellsdestroy cancer cells
• Side effects include fatigue, malaise (feeling unwell), lossSide effects include fatigue, malaise (feeling unwell), loss
of appetite, and skin irritation at the treatment siteof appetite, and skin irritation at the treatment site
• Radiation pneumonitis is the irritation and inflammationRadiation pneumonitis is the irritation and inflammation
of the lung; occurs in 15% of patientsof the lung; occurs in 15% of patients
• It is important that the radiation treatments avoid theIt is important that the radiation treatments avoid the
healthy parts of the lunghealthy parts of the lung
90. Lung cancer stagingLung cancer staging
• Staging is a way of describing a cancer, such as theStaging is a way of describing a cancer, such as the
size of the tumor and where it has spreadsize of the tumor and where it has spread
• Staging is the most important tool doctors have toStaging is the most important tool doctors have to
determine a patient’s prognosisdetermine a patient’s prognosis
• The type of treatment a person receives depends onThe type of treatment a person receives depends on
the stage of the cancerthe stage of the cancer
• Staging is different for non-small cell lung cancer andStaging is different for non-small cell lung cancer and
small cell lung cancersmall cell lung cancer
91. Stage I non-small cell lung cancerStage I non-small cell lung cancer
• Cancer is found only inCancer is found only in
the lungthe lung
• Surgical removalSurgical removal
recommendedrecommended
• Radiation therapy and/orRadiation therapy and/or
chemotherapy may also bechemotherapy may also be
usedused
92. Stage II non-small cell lung cancerStage II non-small cell lung cancer
• The cancer has spread toThe cancer has spread to
lymph nodes in the lunglymph nodes in the lung
• Treatment is surgery toTreatment is surgery to
remove the tumor andremove the tumor and
nearby lymph nodesnearby lymph nodes
• ChemotherapyChemotherapy
recommended;recommended; rradiationadiation
therapy sometimes giventherapy sometimes given
after chemotherapyafter chemotherapy
93. Stage III non-small cell lung cancerStage III non-small cell lung cancer
• The cancer has spread to the lymphThe cancer has spread to the lymph
nodes located in the center of the chest,nodes located in the center of the chest,
outside the lungoutside the lung
• Stage IIIAStage IIIA cancer has spread to lymphcancer has spread to lymph
nodes in the chest, on the same sidenodes in the chest, on the same side
where the cancer originatedwhere the cancer originated
• Stage IIIBStage IIIB cancer has spread to lymphcancer has spread to lymph
nodes on the opposite side of the chest,nodes on the opposite side of the chest,
under the collarbone, or the pleuraunder the collarbone, or the pleura
(lining of the chest cavity)(lining of the chest cavity)
• Surgery or radiation therapy withSurgery or radiation therapy with
chemotherapy recommended forchemotherapy recommended for stagestage
IIIAIIIA
• Chemotherapy and sometimes radiationChemotherapy and sometimes radiation
therapy recommended fortherapy recommended for stage IIIBstage IIIB
94. Stage IV non-small cell lung cancerStage IV non-small cell lung cancer
• The cancer has spreadThe cancer has spread
to different lobes of theto different lobes of the
lung or to other organs,lung or to other organs,
such as the brain,such as the brain,
bones, and liverbones, and liver
• Stage IV non-small cellStage IV non-small cell
lung cancer is treatedlung cancer is treated
with chemotherapywith chemotherapy
95. Small cell lung cancer – all stagesSmall cell lung cancer – all stages
• Patients with limited stage (confined to one area of thePatients with limited stage (confined to one area of the
chest) small cell lung cancer are treated with simultaneouschest) small cell lung cancer are treated with simultaneous
radiation therapy and chemotherapyradiation therapy and chemotherapy
• Patients with extensive stage (not confined to one area ofPatients with extensive stage (not confined to one area of
the chest) small cell lung cancer are treated withthe chest) small cell lung cancer are treated with
chemotherapy onlychemotherapy only
• Because small cell lung cancer can spread to the brain,Because small cell lung cancer can spread to the brain,
preventative radiation therapy to the brain is routinelypreventative radiation therapy to the brain is routinely
recommended to all patients whose tumors disappearrecommended to all patients whose tumors disappear
following chemotherapy and radiation therapyfollowing chemotherapy and radiation therapy
96. Survival RatesSurvival Rates
• 5-year localized survival rate is 49%5-year localized survival rate is 49%
– Localized cancer is cancer that, at the time of diagnosis, hadLocalized cancer is cancer that, at the time of diagnosis, had
not spread to additional sites within the body. Typically, thenot spread to additional sites within the body. Typically, the
earlier a cancer is detected and diagnosed, the more successfulearlier a cancer is detected and diagnosed, the more successful
the treatment, thus enhancing the survival rate. Only 16% ofthe treatment, thus enhancing the survival rate. Only 16% of
lung cancers are diagnosed at this early stagelung cancers are diagnosed at this early stage
• 5-year overall survival rate is 15%5-year overall survival rate is 15%
– The 5-year survival rates represent persons who are living 5The 5-year survival rates represent persons who are living 5
years after diagnosis, whether disease-free, in remission, oryears after diagnosis, whether disease-free, in remission, or
under treatment. They do not imply that 5-year survivors haveunder treatment. They do not imply that 5-year survivors have
been permanently cured of cancer.been permanently cured of cancer.
97. Living with lung cancerLiving with lung cancer
• Patients with lung cancer face the risk of cancer growing back or thePatients with lung cancer face the risk of cancer growing back or the
development of a new lung cancer. All patients must follow up withdevelopment of a new lung cancer. All patients must follow up with
their doctors for regular x-rays, scans, and check-upstheir doctors for regular x-rays, scans, and check-ups
• Many people with lung cancer feel that they will not receive asMany people with lung cancer feel that they will not receive as
much support or help from people around them because they believemuch support or help from people around them because they believe
others will think that their behavior caused the diseaseothers will think that their behavior caused the disease
• Doctors and other members of the health-care team can help patientsDoctors and other members of the health-care team can help patients
and families cope with a diagnosis of lung cancerand families cope with a diagnosis of lung cancer
• Patients can take comfort knowing that the advances being made inPatients can take comfort knowing that the advances being made in
the diagnosis and treatment of lung cancer will provide more andthe diagnosis and treatment of lung cancer will provide more and
more patients with a chance for curemore patients with a chance for cure